New License with the new medical patents... Starting to look good....

WiLAN Subsidiary Enters License Agreement with Stryker (ccnm)

OTTAWA, CANADA--(Marketwired - Sept. 29, 2014) - Top intellectual property licensing company, WiLAN (TSX:WIN)(NASDAQ:WILN) today announced that a wholly-owned subsidiary of the company has granted Stryker Corporation ("Stryker") a license to certain patents related to medical stent technology. WiLAN secured the rights to license the patents through an agreement executed in June 2014.

"We are pleased that Stryker has signed this license," said Jim Skippen, President & CEO. "This license agreement demonstrates our ability to develop and execute licensing programs in new markets such as medical technologies. It also demonstrates our ability to generate timely results for our partners."

The consideration to be paid by Stryker to WiLAN and all other terms of the license agreement are confidential.